The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil

Head and Neck

Volumn 26, Issue 1, 2004, Pages 1-9

  Li, Wei ^a,b   Thompson, Carol H ^b   Cossart, Yvonne E ^b   O'Brien, Christopher J ^a   McNeil, Edward B ^a   Scolyer, Richard A ^c   Rose, Barbara R ^a,b  

^a CANCER INSTITUTE NSW   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cell cycle; Human papillomavirus; P53; PRb; SCC tonsil

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CHEMICAL CARCINOGENESIS; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PAPILLOMA VIRUS; PAPILLOMA VIRUS TYPE 16; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TONSIL CARCINOMA; VIRUS TYPING; WART VIRUS;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS P21(RAS); RETINOBLASTOMA PROTEIN; TONSILLAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0347596814     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10335     Document Type: Article

References (33)

1. Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol 1995;7:229-233.
2. Shin DM, Hittelman WN, Hong WK. Biomarkers in upper aerodigestive tract tumorigenesis: a review. Cancer Epidemiol Biomarkers Prev 1994;3:697-709.
3. Todd R, Donoff RB, Wong DT. The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg 1997;55:613-623.
4. Callender T, el-Naggar AK, Lee MS, et al. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994;74:152-158.
5. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-17.
6. Saenz Robles MT, Symonds H, Chen J, et al. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol Cell Biol 1994;14:2686-2698.
7. Paz IB, Cook N, Odom-Maryon T, et al. Human papillomavirus (HPV) in head and neck cancer. Cancer 1997;79:595-604.
8. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse and survival. Int J Cancer (Pred Oncol) 2000;89:300-304.
9. Wilczynski SP, Lin B T-Y, Xie Y, Paz B. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998;152:145-156.
10. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58:5-13.
11. Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2001;82:238-246.
12. Haraf DJ, Nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Can Res 1996;2:755-762.
13. Snijders PJ, Steenbergen RD, Top B, et al. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 1994;75:2769-2775.
14. Resnick RM, Cornelissen MTE, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-1484.
15. Rose BR, Thompson CH, Chantrill LA, et al. Prevalence and distribution of human papillomavirus type 16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality. Int J Cancer 1992;52:225-228.
16. Shibata DK, Arnheim N, Martin WJ. Detection of human papillomavirus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 1988;167:225-230.
17. Stephen AL, Thompson CH, Tattersall MH, Cossart YE, Rose BR. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 2000;86:695-701.
18. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3'ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-1062.
19. Boxman IL, Berkhout RJ, Mulder LH, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997;108:712-715.
20. Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000;115:396-401.
21. Cip1Waf1 protein accumulation in head-and-neck cancer. Int J Cancer (Pred Oncol) 1997;74:383-389.
22. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogene potential in cervical and genital lesions. Am J Pathol 1998;153:1741-1748.
23. Pinbord JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin, New York: Springer; 1997. p 11-12.
24. Kip1 expression in oral squamous cell carcinoma in Taiwan. Oral Oncology 2002;38:172-178.
25. Smith EM, Pignatari SS, Gray SD, et al. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 1993;119:554-557.
26. Klussmann JP, Weienborn SJ, Wieland U, et al. Prevalence, distribution and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001;92:2875-2884.
27. zur Hausen H. Papillomavirus infection-a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-F78.
28. Friedman M, Lim JW, Manders E, et al. Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 2001;23:280-285.
29. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387:296-299.
30. INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999;5:2810-19.
31. Cip1/Waf1/Sdi1 are identified by HPV16-E6 interaction and correlate with life span and cellular Senescence. Exp Cell Res 1999;247:168-175.
32. Venkatesan TK, Kuropkat C, Caldarelli DD, et al. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx. Laryngoscope 1999;109:1329-1333.
33. Lindel K, Beer KT, Laissue J, et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx. Cancer 2001;92:805-813.